Cross Talk among Substances Can Answer Questions Raised by Clinical Trials
Tatsuo Shimosawa · Hypertension Research · 2008
Kon V, Jabs K : Angiotensin in atherosclerosis. Curr Opin Nephrol Hypertens 2004; 13 : 291–297. Article CAS Google Scholar Ferrario CM, Strawn WB : Role of the renin-angiotensinaldosterone system and proinflammatory mediators in cardiovascular disease. Am J Cardiol 2006; 98 : 121–128. Article CAS Google Scholar Kanome T, Watanabe T, Nishio K, Takahashi K, Hongo S, Miyazaki A : Angiotensin II upregulates acyl-CoA:cholesterol acyltransferase-1 via angiotensin II type 1 receptor in human monocyte-macrophages. Hypertens Res 2008; 31 : 1801–1810. Article CAS Google Scholar Tardif JC, Grégoire J, L'Allier PL, et al : Effects of the acyl coenzyme A:cholesterol acyltransferase inhibitor avasimibe on human atherosclerotic lesions. Circulation 2004; 110 : 3372–3377. Article CAS Google Scholar Nissen SE, Tuzcu EM, Brewer HB, et al : Effect of ACAT inhibition on the progression of coronary atherosclerosis. N Engl J Med 2006; 354 : 1253–1263. Article CAS Google Scholar Download references